Publication:
Spectral domain optical coherence tomography findings of patients under treatment for pediatric acute lymphoblastic leukemia

dc.contributor.authorGelişken, Öner
dc.contributor.buuauthorYalçınbayır, Özgür
dc.contributor.buuauthorBaytan, Birol
dc.contributor.buuauthorCan, Başak
dc.contributor.buuauthorEvim, Melike Sezgin
dc.contributor.buuauthorYıldız, Meral
dc.contributor.buuauthorGüneş, Adalet Meral
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentOftalmoloji Bölümü
dc.contributor.departmentÇocuk Hematoloji Ana Bilim Dalı
dc.contributor.researcheridAAH-6625-2021
dc.contributor.researcheridAAH-1885-2021
dc.contributor.scopusid8702056700
dc.contributor.scopusid6506622162
dc.contributor.scopusid56406209200
dc.contributor.scopusid36667380300
dc.contributor.scopusid35791194600
dc.contributor.scopusid24072843300
dc.date.accessioned2023-02-03T12:33:59Z
dc.date.available2023-02-03T12:33:59Z
dc.date.issued2016-12-16
dc.description.abstractPURPOSE To investigate the use of spectral domain optical coherence tomography (SD-OCT) findings in pediatric acute lymphoblastic leukemia (ALL) patients. METHODS Children that were diagnosed with precursor B-cell ALL and classified as belonging to the medium-risk group for relapse were selected for this study. Individuals who were in. continuous remission and on maintenance therapy were included in the study group. Cases that had central nervous system involvement were excluded. Age-matched, otherwise healthy children were selected for the control group. Each study participant underwent a comprehensive eye examination and SD-OCT evaluation. Thickness measurements were made within the retinal nerve fiber layer (RNFL), central macula, posterior polar, and peripapillary choroid. RESULTS A total of 112 eyes of 56 children were included: 54 eyes in the study group and 58 in the control group. Compared to the control group, subfoveal and temporal choroidal thicknesses of the posterior pole were significantly thinner in the study group (P < 0.005). Similarly, peripapillary choroidal thicknesses were significantly thinner in most sectors of the study group (P < 0.005). There were no major differences between groups in terms of central macular thicknesses and overall RNFL thicknesses. CONCLUSIONS Evidence of choroidal attenuation was found in this subgroup of pediatric ALL patients. Further studies are warranted to clarify the utility of SD-OCT in detecting subclinical ocular involvement and monitoring treatment response and risk of relapse in patients with pediatric leukemia.
dc.identifier.citationYalçınbayır, Ö. vd. (2017). ''Spectral domain optical coherence tomography findings of patients under treatment for pediatric acute lymphoblastic leukemia''. Journal of AAPOS, 21(2), 131-135.
dc.identifier.endpage135
dc.identifier.issn1091-8531
dc.identifier.issn1528-3933
dc.identifier.issue2
dc.identifier.pubmed28315402
dc.identifier.scopus2-s2.0-85017181374
dc.identifier.startpage131
dc.identifier.urihttps://doi.org/10.1016/j.jaapos.2016.12.002
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S1091853117301982
dc.identifier.urihttp://hdl.handle.net/11452/30831
dc.identifier.volume21
dc.identifier.wos000401309700010
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier
dc.relation.collaborationSanayi
dc.relation.journalJournal of AAPOS
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectOphthalmology
dc.subjectPediatrics
dc.subjectChoroidal thickness
dc.subjectOphthalmic manifestations
dc.subjectInvolvement
dc.subjectChildren
dc.subject.emtreePhenylephrine
dc.subject.emtreeTropicamide
dc.subject.emtreeAcute lymphoblastic leukemia
dc.subject.emtreeAdolescent
dc.subject.emtreeAdult
dc.subject.emtreeArticle
dc.subject.emtreeCentral macular thickness
dc.subject.emtreeChild
dc.subject.emtreeChoroid
dc.subject.emtreeChoroidal thickness
dc.subject.emtreeClinical article
dc.subject.emtreeClinical evaluation
dc.subject.emtreeControlled study
dc.subject.emtreeEye examination
dc.subject.emtreeFemale
dc.subject.emtreeHigh risk population
dc.subject.emtreeHuman
dc.subject.emtreeLeukemia relapse
dc.subject.emtreeLeukemia remission
dc.subject.emtreeMaintenance therapy
dc.subject.emtreeMale
dc.subject.emtreeOptical coherence tomography device
dc.subject.emtreePediatrics
dc.subject.emtreePilot study
dc.subject.emtreePre B iymphocyte
dc.subject.emtreePriority journal
dc.subject.emtreeRefraction error
dc.subject.emtreeRetina fovea
dc.subject.emtreeRetina macula lutea
dc.subject.emtreeRetinal nerve fiber layer thickness
dc.subject.emtreeSpectral domain optical coherence tomography
dc.subject.emtreeTreatment response
dc.subject.emtreeAcute lymphoblastic leukemia
dc.subject.emtreeBone marrow
dc.subject.emtreeComplication
dc.subject.emtreeCross-sectional study
dc.subject.emtreeIncidence
dc.subject.emtreeMortality
dc.subject.emtreeMultimodality cancer therapy
dc.subject.emtreeNerve fiber
dc.subject.emtreeOptic disk
dc.subject.emtreeOptical coherence tomography
dc.subject.emtreePathology
dc.subject.emtreePreschool child
dc.subject.emtreeProcedures
dc.subject.emtreeRetina disease
dc.subject.emtreeRetina ganglion cell
dc.subject.emtreeRetrospective study
dc.subject.meshAdolescent
dc.subject.meshBone marrow
dc.subject.meshChild
dc.subject.meshChild, preschool
dc.subject.meshChoroid
dc.subject.meshCombined modality therapy
dc.subject.meshCross-sectional studies
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshIncidence
dc.subject.meshMacula lutea
dc.subject.meshMale
dc.subject.meshNerve fibers
dc.subject.meshOptic disk
dc.subject.meshPrecursor cell lymphoblastic leukemia-lymphoma
dc.subject.meshRetinal diseases
dc.subject.meshRetinal ganglion cells
dc.subject.meshRetrospective studies
dc.subject.meshTomography, optical coherence
dc.subject.meshTurkey
dc.subject.scopusMethotrexate; Cytarabine; Precursor Cell Lymphoblastic Leukemia-Lymphoma
dc.subject.wosOphthalmology
dc.subject.wosPediatrics
dc.titleSpectral domain optical coherence tomography findings of patients under treatment for pediatric acute lymphoblastic leukemia
dc.typeArticle
dc.wos.quartileQ4
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Oftalmoloji Bölümü
local.contributor.departmentTıp Fakültesi/Çocuk Hematoloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: